Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Plasmin triggers a switch-like decrease in thrombospondin-dependent activation of TGF-β1.

Venkatraman L, Chia SM, Narmada BC, White JK, Bhowmick SS, Forbes Dewey C Jr, So PT, Tucker-Kellogg L, Yu H.

Biophys J. 2012 Sep 5;103(5):1060-8.

2.

HGF regulates the activation of TGF-β1 in rat hepatocytes and hepatic stellate cells.

Narmada BC, Chia SM, Tucker-Kellogg L, Yu H.

J Cell Physiol. 2013 Feb;228(2):393-401. doi: 10.1002/jcp.24143.

PMID:
22718393
3.

Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.

Guda K, Claffey KP, Dong M, Nambiar PR, Rosenberg DW.

Mol Carcinog. 2003 May;37(1):51-9.

PMID:
12720300
4.
5.

Potential mechanisms for the plasmin-mediated release and activation of latent transforming growth factor-beta1 from the extracellular matrix of growth plate chondrocytes.

Pedrozo HA, Schwartz Z, Robinson M, Gomes R, Dean DD, Bonewald LF, Boyan BD.

Endocrinology. 1999 Dec;140(12):5806-16.

PMID:
10579347
6.

Thrombospondin-1 and transforming growth factor beta-1 upregulate plasminogen activator inhibitor type 1 in pancreatic cancer.

Albo D, Berger DH, Vogel J, Tuszynski GP.

J Gastrointest Surg. 1999 Jul-Aug;3(4):411-7.

PMID:
10482694
7.

Thrombospondin 1 mediates angiotensin II induction of TGF-beta activation by cardiac and renal cells under both high and low glucose conditions.

Zhou Y, Poczatek MH, Berecek KH, Murphy-Ullrich JE.

Biochem Biophys Res Commun. 2006 Jan 13;339(2):633-41.

PMID:
16310163
8.

Bile acid-mediated thrombospondin-1 induction in hepatocytes leads to transforming growth factor-beta-dependent hepatic stellate cell activation.

Myung SJ, Yoon JH, Gwak GY, Kim W, Yang JI, Lee SH, Jang JJ, Lee HS.

Biochem Biophys Res Commun. 2007 Feb 23;353(4):1091-6.

PMID:
17204245
9.

Steady states and dynamics of urokinase-mediated plasmin activation in silico and in vitro.

Venkatraman L, Li H, Dewey CF Jr, White JK, Bhowmick SS, Yu H, Tucker-Kellogg L.

Biophys J. 2011 Oct 19;101(8):1825-34. doi: 10.1016/j.bpj.2011.08.054.

11.

Cooperation of liver cells in health and disease.

Kmieć Z.

Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. Review.

PMID:
11729749
12.

Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36.

Yehualaeshet T, O'Connor R, Green-Johnson J, Mai S, Silverstein R, Murphy-Ullrich JE, Khalil N.

Am J Pathol. 1999 Sep;155(3):841-51.

13.

Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo.

Daniel C, Wiede J, Krutzsch HC, Ribeiro SM, Roberts DD, Murphy-Ullrich JE, Hugo C.

Kidney Int. 2004 Feb;65(2):459-68.

14.

The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer.

Rojas A, Meherem S, Kim YH, Washington MK, Willis JE, Markowitz SD, Grady WM.

Int J Cancer. 2008 Jul 1;123(1):14-21. doi: 10.1002/ijc.23608.

16.

MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4.

He Y, Huang C, Sun X, Long XR, Lv XW, Li J.

Cell Signal. 2012 Oct;24(10):1923-30. doi: 10.1016/j.cellsig.2012.06.003.

PMID:
22735812
17.

Role of ERK1/2 and p38 mitogen-activated protein kinases in the regulation of thrombospondin-1 by TGF-beta1 in rat proximal tubular cells and mouse fibroblasts.

Nakagawa T, Lan HY, Glushakova O, Zhu HJ, Kang DH, Schreiner GF, Böttinger EP, Johnson RJ, Sautin YY.

J Am Soc Nephrol. 2005 Apr;16(4):899-904.

19.

Suppression of latent transforming growth factor (TGF)-beta1 restores growth inhibitory TGF-beta signaling through microRNAs.

Dogar AM, Towbin H, Hall J.

J Biol Chem. 2011 May 6;286(18):16447-58. doi: 10.1074/jbc.M110.208652.

20.

Sodium valproate blocks the transforming growth factor (TGF)-β1 autocrine loop and attenuates the TGF-β1-induced collagen synthesis in a human hepatic stellate cell line.

Watanabe T, Tajima H, Hironori H, Nakagawara H, Ohnishi I, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Tani T, Fujimura T, Ota T, Wakayama T, Iseki S, Harada S.

Int J Mol Med. 2011 Dec;28(6):919-25. doi: 10.3892/ijmm.2011.768.

PMID:
21822535
Items per page

Supplemental Content

Support Center